Shingles can only develop in someone who already carries varicella-zoster virus (VZV) in their nerve cells, so if you have genuinely never been infected with VZV, you cannot get shingles. The catch is that “never had chickenpox” and “never been infected” are not always the same thing. A surprisingly large share of people who are certain they skipped chickenpox actually carry the virus without knowing it, and even the chickenpox vaccine can quietly set the stage for a later shingles episode.
Why Shingles Requires a Prior Infection
Shingles is not a new infection you catch from the environment. It is the reawakening of VZV that has been hiding in your own nervous system, sometimes for decades. During a first encounter with VZV, whether as a child with chickenpox or as an adult exposed to the virus, VZV travels along nerve fibers and settles into clusters of nerve cells called ganglia near the spine and brain. Once there, the virus stops replicating. It shuts down almost all of its gene activity and produces no new viral particles. It simply sits in the neuron’s nucleus in a dormant loop of DNA, waiting.1PubMed Central. Varicella zoster virus (VZV)-human neuron interaction Lab models confirm that during this latent phase, the viral genome shifts into a circular configuration and viral messenger RNA is almost undetectable.2PubMed Central. In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency
Years or decades later, something tips the balance and the virus wakes up. It begins replicating inside the nerve cell and travels back down the nerve fiber to the skin, producing the painful, blistering rash we call shingles. What exactly triggers that reactivation is still not fully understood. Researchers know that aging and a weakened immune system are the big risk factors, but the precise molecular switch remains unidentified.1PubMed Central. Varicella zoster virus (VZV)-human neuron interaction The important takeaway is that without VZV already living in your ganglia, there is nothing to reactivate. No prior infection, no shingles.
You May Have Had Chickenpox Without Knowing It
This is where things get tricky. VZV is extraordinarily contagious, and not everyone who gets infected develops the classic itchy rash that parents and doctors recognize. Some infections, particularly those in very young children or people with partial immunity from maternal antibodies, produce such mild symptoms that nobody notices. A child might develop a handful of spots that get mistaken for insect bites, run a low-grade fever for a day, and move on. Years later, that person honestly believes they were never sick.
Studies looking at blood antibodies paint a striking picture of how unreliable memory is here. In one study of children up to 14 years old, a reported history of “no chickenpox” turned out to be wrong nearly nine times out of ten: the negative predictive value of a negative history was only about 11%, meaning roughly 89% of kids who denied having chickenpox actually carried VZV antibodies.3PubMed. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age A separate study among Belgian healthcare workers found a similarly poor negative predictive value of just 3.4% for recalled history.4Occupational and Environmental Medicine. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study In practical terms, if you grew up before widespread vaccination and believe you never had chickenpox, the odds are high that you actually did, you just don’t remember it.
This matters because those subclinical infections still deposit VZV into your ganglia. The virus doesn’t need a dramatic rash to establish latency. Even a barely noticeable infection sets the same trap in the nerve cells, and that means the virus can reactivate as shingles later in life.
The Vaccine Can Also Set the Stage
The varicella vaccine uses a live but weakened strain of VZV called vOka. It is excellent at preventing full-blown chickenpox, but because it is a live virus, it behaves in some ways like its wild cousin. After vaccination, vOka can travel to the ganglia and establish latency in the same manner as wild-type VZV.5IDCases. Recurrent vaccine-strain varicella zoster virus reactivation in a child with acute lymphatic leukemia That means a vaccinated person who never had clinical chickenpox can still, in rare cases, develop shingles later on, caused by the vaccine strain rather than the wild virus.
Case reports have documented this in both immunocompromised and immunocompetent individuals, including children.6PubMed. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child These episodes tend to be milder than shingles caused by wild-type VZV, and they are uncommon. But they do answer the title question with an important nuance: even if you were vaccinated instead of naturally infected, you are not completely exempt from shingles risk. You simply carry a weaker version of the virus, and the chance of reactivation is lower.
What Happens If You Are Truly VZV-Naive
If you are one of the rare adults who genuinely has no VZV antibodies, either because you were never exposed and never vaccinated, your risk is not shingles. Your risk is primary chickenpox. And adult-onset chickenpox is a more serious disease than the childhood version most people picture. The most common severe complication in adults is varicella pneumonia, which occurs at a rate roughly 25 times higher in adults than in children.7European Respiratory Journal. Varicella pneumonia in adults Hospitalization and mortality rates from adult chickenpox have been climbing in recent decades as more adults reach adulthood without natural exposure.
The practical implication is worth underscoring. If you are an adult who has no record of chickenpox or vaccination and you are around someone with active shingles, you would not “catch” shingles from them. What could happen is that the VZV shed from their rash lesions could give you chickenpox. Shingles lesions contain live virus, and while transmission from localized shingles typically requires direct contact with the blisters, at least one documented case demonstrated airborne spread from a shingles patient to a household contact who then developed chickenpox.8PubMed Central. Varicella caused by airborne transmission of a localised herpes zoster infection in a family After that chickenpox infection, though, the virus would settle into your ganglia and you would then carry a future shingles risk.
How Your Immune System Keeps VZV in Check
Interestingly, VZV latency in the ganglia does not rely on the immune system to get started. Animal model work using human nerve tissue has shown that the virus transitions from active replication to latency on its own within a few weeks, without any input from adaptive immunity.9PubMed Central. Varicella-zoster virus infection of human dorsal root ganglia in vivo But once latency is established, your immune system becomes the main force keeping the virus dormant. T cells that specifically recognize VZV patrol the body and suppress any attempt by the virus to reactivate.
This is why shingles tends to show up when immunity wanes. The frequency of VZV-specific immune cells in the blood begins to decline after about age 30, which gradually loosens the lid on the latent virus.10Cell Press. Immune senescence and diseases of aging By the time you reach your 60s or 70s, the surveillance is thin enough that the virus can slip through. This age-related decline is the single biggest risk factor for shingles in the general population.
People with suppressed immune systems face a much steeper risk. A systematic review of shingles in immunocompromised adults in the United States found elevated rates across multiple conditions: among people aged 18 to 49, the incidence per 1,000 person-years was about 40 for hematopoietic cell transplant recipients, 18 for people living with HIV, 13 for solid organ transplant recipients, and 8 for people with cancer.11PubMed Central. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review For context, the general-population rate in that age group is typically well below 5 per 1,000 person-years. Transplant recipients face particularly high rates because their anti-rejection medications deliberately dampen the immune response that would normally keep VZV quiet.
Shingles Without the Rash
One scenario that further complicates the picture is VZV reactivation that never produces a visible rash. This condition, called zoster sine herpete, involves the same nerve pain, burning, or tingling that comes with shingles, but no blisters appear on the skin. It can cause chronic radicular pain and, in some cases, neurological problems typically associated with visible shingles.12PubMed Central. Neurological disease produced by varicella zoster virus reactivation without rash Because there is no rash, it often goes undiagnosed or gets attributed to something else entirely.
There is also evidence that the virus can reactivate at a low level without causing any symptoms at all. VZV DNA has been detected in the blood cells of elderly individuals who had no skin lesions, no pain, and no signs of neurological disease.13PubMed. Varicella-zoster virus reactivation without rash These subclinical flickers of reactivation may actually help by boosting the immune system’s memory of VZV, acting as a natural booster shot. This is one reason researchers have debated whether widespread childhood vaccination against chickenpox might paradoxically increase shingles rates in older adults by removing the periodic natural boosting they used to get from exposure to children with chickenpox.
Did Childhood Vaccination Change Shingles Rates?
When the United States introduced universal childhood varicella vaccination in 1995, some mathematical models predicted that removing circulating wild-type VZV from the community would eventually cause a spike in shingles among older adults who had previously had chickenpox. The logic was that those adults would lose the immune boosting they got from periodic re-exposure to the virus through contact with infected children.
Decades of real-world data have not supported that prediction. Studies comparing shingles incidence in birth cohorts before and after the vaccination program found no evidence that the program increased shingles rates among adults who had previously had chickenpox.14The Journal of Infectious Diseases. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program Launch A comprehensive review echoed this, finding no evidence that the U.S. varicella vaccination program raised shingles incidence in the general adult population above existing baseline trends, while shingles incidence in children has actually declined.15PubMed. Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States The early mathematical models, it turned out, overestimated how much external boosting mattered.
What Shingles Does When It Strikes
For anyone who does carry VZV and experiences a reactivation, the experience ranges from a nuisance to a serious medical event. The rash itself typically appears as a band of blisters on one side of the body, following the path of the affected nerve. It is painful, often intensely so, and the pain can begin days before the blisters appear. The acute phase usually resolves within two to four weeks, but the aftermath is what concerns doctors most.
The most feared complication is postherpetic neuralgia, persistent pain in the area where the rash occurred that lasts more than three months after the blisters heal.16PubMed Central. Herpes zoster (shingles) and postherpetic neuralgia The pain can be burning, stabbing, or electric-shock-like, and it is notoriously difficult to treat. The risk of postherpetic neuralgia rises sharply with age, which is one reason the shingles vaccine is so strongly recommended for older adults.
When the virus reactivates in the nerve branch that supplies the eye and forehead, the condition is called herpes zoster ophthalmicus. Roughly 4 to 20% of all shingles cases involve this nerve.17PubMed Central. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention About half of those patients develop some form of eye disease, including inflammation of the cornea, the interior of the eye, or the retina. Some of the more severe eye complications, such as acute retinal necrosis, can threaten vision permanently.18PubMed Central. Eye and Periocular Skin Involvement in Herpes Zoster Infection
Shingles in Children and Infants
Most people associate shingles with older adults, but children can develop it too, especially if they were infected with VZV very early in life. A review of infantile herpes zoster found that babies who were exposed to chickenpox in the first few months of life, or even in the womb, could develop shingles during infancy or early childhood.19JAMA Dermatology. Herpes Zoster in the First Year of Life Following Postnatal Exposure to Varicella-zoster Virus: Four Case Reports and a Review of Infantile Herpes Zoster A community-based follow-up study quantified this: children who caught VZV before age two months had a shingles incidence roughly five times higher during the first decade of life compared with children who caught it between two and eleven months of age.20PubMed. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study
The likely explanation is that a newborn’s immune system is immature and does not mount a robust memory response to VZV. The virus establishes latency, but the immune surveillance that would normally keep it suppressed for decades is less effective, allowing reactivation to happen sooner. Pediatric shingles tends to be milder than in adults and rarely leads to postherpetic neuralgia, but it is not unheard of and it underscores that shingles is not exclusively a disease of old age.
How to Find Out If You Carry the Virus
If you genuinely do not know whether you have ever been infected with VZV, a simple blood test can settle the question. The test measures VZV-specific IgG antibodies. A positive result means you have been infected at some point, whether or not you remember a rash, and you carry the latent virus. A negative result means you are susceptible to primary chickenpox and should consider varicella vaccination if you have not already been vaccinated.
This testing is commonly recommended for healthcare workers, pregnant women, and immunocompromised individuals who may face higher stakes from either a primary infection or a reactivation. For most other adults, the practical approach is straightforward: if you were born before the mid-1990s in a country without a varicella vaccination program, you were almost certainly infected as a child regardless of what you remember. If you were born after widespread vaccination began and received the vaccine, you likely carry the vaccine strain. Either way, you are a candidate for the recombinant shingles vaccine (Shingrix) once you reach the recommended age, because the vaccine works by boosting VZV-specific immunity rather than preventing a new infection.
The Economic Weight of Shingles
Shingles is not just a medical problem but a significant economic one. A systematic review of the economic burden found that direct costs, primarily from doctor visits and prescription medications, represent the largest share, and that those costs have been rising over time. Increasing age and the presence of other health conditions predicted higher direct costs, while people who developed shingles during their working years faced substantial indirect costs from lost productivity.21PubMed Central. Evaluation of the economic burden of Herpes Zoster (HZ) infection A population-based Canadian study tracking costs over more than a decade found that drug costs per episode rose significantly, while hospitalization rates declined, likely reflecting a shift toward more outpatient management with antiviral medications.22PubMed Central. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia For an individual patient, especially one who develops postherpetic neuralgia, the cost of ongoing pain management can extend for months or years.
VZV’s Long Evolutionary History With Humans
Varicella-zoster virus has been a human companion for a very long time. Genetic analysis suggests that the ancestral VZV migrated out of Africa with early humans roughly 200,000 years ago. As populations moved into temperate climates with less ultraviolet radiation, the virus appears to have traded UV resistance for other survival advantages, potentially including a greater tendency to reactivate as shingles. If that hypothesis holds, the reactivation mechanism that causes so much suffering today may have been positively selected because it gave the virus more opportunities to spread to new hosts through fresh rounds of chickenpox transmission.23PubMed Central. Ultra-violet radiation is responsible for the differences in global epidemiology of chickenpox and the evolution of varicella-zoster virus as man migrated out of Africa This evolutionary perspective is still being tested, but it offers a framework for understanding why VZV is so remarkably good at hiding in neurons and coming back.